MENU CLIENT LOGIN Healthcare Investment Banking Paving Your Path to Success. Investment Banking Capabilities Research Capabilities Leveraging BTIG’s full resources, our Healthcare Investment Banking Group works alongside established and emerging, private and public healthcare companies to help them grow and capitalize on valuable market opportunities. With seasoned healthcare-focused banking professionals in Boston, New York and San Francisco, we collaborate with clients to execute transformative transactions. Intellectual Capital, Individually Tailored Solutions, Unbiased Advisory Services and Unparalleled Support. We deliver deep sector and transactional expertise across biotechnology, life science and diagnostic tools, medical technology and specialty pharmaceuticals. Regardless of the stage of their development, BTIG’s knowledgeable, senior team delivers operational and financial guidance to corporate clients across the healthcare spectrum. And, with our extensive industry relationships, we offer investor perspective and insights that help adjust and evolve corporate strategy. Biotechnology Life Science Tools Medical Technology Diagnostic Tools Specialty Pharmaceuticals MEET OUR BANKERS K.C. Stone Managing Director, Head of Healthcare Investment Banking Chris Dorn Managing Director, Healthcare Investment Banking Doug Kleinberg Managing Director, Healthcare Investment Banking Karen Koski Managing Director, Healthcare Investment Banking J. Rory Rohan Managing Director, Investment Banking Mark Secrest Managing Director, Healthcare Investment Banking Lin Yu, PhD Managing Director, Healthcare Investment Banking RECENT TRANSACTIONS October 2021 $75,600,000 IPO Lead Manager September 2021 $230,000,000 IPO Lead Manager August 2021 $29,999,999 Follow-On Sole Bookrunner July 2021 $78,833,337 IPO Lead Manager See our Healthcare Research capabilities Giving clients a full range of research capabilities for healthcare-related entities View More PRESS RELEASES December 17, 2020 BTIG to Host Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference on February 17-19, 2021 - Firm Event to Feature Key Opinion Leaders and Nearly 100 Corporate Management Teams BTIG announced today that the “BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference” will take place on Wednesday, February 17th through Friday, February 19, 2021. The firm expects to host nearly 100 corporate management teams throughout the three-day event which includes thematic panels, company presentations, fireside chats and one-on-one meetings. November 19, 2020 BTIG Investment Banking Division Adds Healthcare Information Technology and Digital Health Specialist Chris Dorn as a Managing Director BTIG announced today that Chris Dorn has joined the firm as a Managing Director within its Healthcare Investment Banking division. Mr. Dorn will focus on healthcare information technology (IT) and digital health companies and report to K.C. Stone, Managing Director and Head of Healthcare Investment Banking, at BTIG. August 6, 2020 BTIG Healthcare Investment Banking Team Adds Managing Director, Private Placement Specialist J. Rory Rohan BTIG announced today that it has hired J. Rory Rohan as a Managing Director within its Healthcare Investment Banking division. Mr. Rohan will be based in the firm’s New York office, and will report to K.C. Stone, Managing Director and Head of Healthcare Investment Banking, at BTIG. July 22, 2020 BTIG to Host Virtual Biotechnology Conference on August 10-11, 2020 – Firm Event to Feature Key Opinion Leaders and More Than 120 Corporate Management Teams BTIG announced today that the “BTIG Virtual Biotechnology Conference” will take place on Monday, August 10th through Tuesday, August 11, 2020. The conference will be hosted by BTIG Biotechnology Analysts Dae Gon Ha, PhD, Julian Harrison, Robert “Bert” Hazlett, and Thomas Shrader, PhD, CFA, as well as BTIG Healthcare Strategy and Franchise Sales Specialists Michael Karmiol, and Mikhail Keyserman, CMT, CFTe. January 23, 2020 BTIG Adds Lin Yu, PhD, to Launch New Healthcare Royalty Monetization Business BTIG announced today that Lin Yu, PhD, has joined the firm to launch a new Healthcare Royalty Monetization practice from within its Investment Banking unit. BTIG’s healthcare expertise makes the firm the ideal partner for its corporate and institutional investor clients exploring the purchase and sale of royalty streams. January 9, 2020 BTIG to Host Targeted Therapeutics Conference on February 24, 2020 in New York - Industry Event to Feature Key Opinion Leaders and Corporate Management Teams BTIG announced today that the “BTIG Targeted Therapeutics Conference” will take place on Monday, February 24, 2020 in New York. The conference will be hosted by BTIG Biotechnology Analysts Tim Chiang, Robert “Bert” Hazlett, Amanda Murphy, CFA, and Thomas Shrader, PhD, CFA, and BTIG Healthcare Strategy and Franchise Sales Specialists Mikhail Keyserman, CMT, CFTe, and Michael Karmiol. OTHER BTIG PRODUCTS & SERVICES Institutional Sales & Trading With a broad global footprint, connects clients with experienced traders, and state-of-the-art technology that quickly responds and delivers results. Outsource Trading & Prime Brokerage Expert prime brokerage, outsource trading, capital introduction and electronic execution tools for emerging and established fund managers. Research & Strategy Contextualizing critical data points, BTIG helps clients connect the dots, focus on the big picture and elevate what matters most. ABOUT US NEWS & EVENTS CONTACT US Home Disclosures Report Disclaimer Imagery Use BTIG, LLC — Member of FINRA and SIPC brokercheck.finra.org Copyright 2021 BTIG, LLC. All Rights Reserved.